$BIO
SEC EDGAR Filings Hub
2 Filings
$BIO · BIO-RAD LABORATORIES, INC. SEC Filings
Position Tracker tracks 2 SEC EDGAR filings for BIO-RAD LABORATORIES, INC. ($BIO) from November 5, 2026 through November 5, 2026, including 0 Form 10-K annual reports, 1 Form 10-Q quarterly earnings reports, 1 Form 8-K current event disclosures, and 0 Form 4 insider equity transactions. Select any filing below to read the full AI summary, key financial takeaways, and original SEC.gov document.
Check $BIO portfolio concentration →
View $BIO Congress trades →
Research $BIO stock →
All SEC filings →
Total Filings2
10-K / 10-Q Reports1
8-K Material Events1
Form 4 Insider0
High-Impact0
Latest FilingNovember 5, 2026
Browse SEC Filings by Form Type
Latest $BIO SEC Filings & AI Summaries (2)
November 5, 2026
$BIO 8-K — BIO-RAD LABORATORIES, INC.
The headline GAAP swing is an investment-mark-to-market artifact, while core non-GAAP results show modest margin expansion and a return to currency-neutral growth.
November 4, 2026
$BIO 10-Q — BIO-RAD LABORATORIES, INC.
The headline profit is almost entirely a mark-to-market gain on Bio-Rad's Sartorius stake, masking an operating loss and impairment.